Research Article
Mortality in Elderly Patients Taking Furosemide: Prospective Cohorts Study
Table 4
Multivariate models of mortality at 5 years.
| N = 597 | HR | IC 95% | |
| Age | 1.10 | 1.07–1.13 | <0.01 | Sex (men vs. women) | 1.96 | 1.32–2.91 | <0.01 | Smoking (yes vs. no) | 0.94 | 0.70–1.26 | 0.66 | Functional capacity (Katz index) | 1.14 | 1.02–1.26 | 0.02 | Muscle strength | 0.99 | 0.97–1.01 | 0.17 | Comorbidity | 1.07 | 0.98–1.16 | 0.14 | Cognition Pfeiffer index | 1.13 | 1.05–1.22 | <0.01 | Heart disease | 0.94 | 0.69–1.28 | 0.69 | Diastolic blood pressure | 0.99 | 0.98–1.00 | 0.03 | Pulse pressure | 1.00 | 0.99–1.01 | 0.91 | Furosemide (yes vs. no) | 2.31 | 1.48–3.61 | <0.01 | Nitrites (yes vs. no) | 0.40 | 0.86–2.57 | 0.16 | Furosemide—nitrites (interaction) | 0.87 | 0.29–2.58 | 0.80 |
|
|